S1312, Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Leukemia

Clinical trial NCT01925131 · COMPLETED

Trial details

NCT number: NCT01925131
Sponsor: SWOG Cancer Research Network
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Leukemias of Ambiguous Lineage B-cell Adult Acute Lymphoblastic Leukemia Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Burkitt Lymphoma

Start date: 2014-06-13
Primary completion: 2022-01-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.